Evidence map›Paper›PMID 42368712›Full record

ArticleMaterials today. Bio2026

Advancing photocytotoxicity evaluation of nitric oxide derivative-ruthenium complex in 3D biofabricated breast cancer models.

Amanda Blanque Becceneri, Suihong Liu, Sendegul Yildirim, Myoung Hwan Kim, Youdi Liu, Ilayda Namli, Todd M Umstead, Zissis C Chroneos, Roberto Santana da Silva, Ibrahim T Ozbolat

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amanda Blanque BecceneriThe Huck Institutes of Life Sciences, Penn State University, University Park, PA, 16802, USA.
Suihong LiuThe Huck Institutes of Life Sciences, Penn State University, University Park, PA, 16802, USA.
Sendegul YildirimThe Huck Institutes of Life Sciences, Penn State University, University Park, PA, 16802, USA.
Myoung Hwan KimThe Huck Institutes of Life Sciences, Penn State University, University Park, PA, 16802, USA.
Youdi LiuThe Huck Institutes of Life Sciences, Penn State University, University Park, PA, 16802, USA.
Ilayda NamliThe Huck Institutes of Life Sciences, Penn State University, University Park, PA, 16802, USA.
Todd M UmsteadDepartment of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA, USA.
Zissis C ChroneosDepartment of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA, USA.
Roberto Santana da SilvaSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (USP), Av. Do Café, Vila Monte Alegre, Ribeirão Preto, São Paulo, 14040-903, Brazil.
Ibrahim T OzbolatThe Huck Institutes of Life Sciences, Penn State University, University Park, PA, 16802, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer remains a major health challenge, emphasizing the need for innovative therapies. Photodynamic therapy (PDT) uses light-activated photosensitizers (PSs) to induce targeted cancer cell death, but clinical translation is limited by low tumor specificity, toxicity, and inadequate

Indexed as

3D bioprintingBreast cancerPatient-derived organoidsPhotodynamic therapyRuthenium complexSpheroids

Identifiers

PMID42368712
PMCPMC13293746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.